What the company does
3D Medicines Inc., a biopharmaceutical company, researches, develops, and commercializes oncology products and other drug candidates for the treatment of patients with various cancers in the People's Republic of China. The company offers Envafolimab, a PD-L1 antibody in the form of subcutaneous injection for the treatment of previously treated microsatellite instability-high (MSI-H)/mismatch repair deficient(dMMR) advanced solid tumors. It is also developing Envafolimab, which is in Phase III clinical trials for advanced BTC and NSCLC; and in Phase II clinical trials G/GEJ and TMB-H advanced cancer, EC, HCC, CRC, NSCLC, microsatellite stable CRC, and dMMR advanced …
What the weekly tape is saying
1244 closed the latest completed week at 2.91 HKD. The 4-week return is 0.0% and the 12-week return is -29.2%. Trend Signal is inactive, Market Dynamics is -0.48. Setup signature: Risk-first tape with a 17/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 4.23 HKD
- Vs Trend Line
- -31.2%
- Fair Value
- 9.63 HKD
- Vs Fair Value
- -69.8%
- 52W High
- 10.02 HKD
- 52W Low
- 2.52 HKD
- Drawdown
- -71.0%
- Range Position
- 5.2%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 0 weeks
- 52W Active Weeks
- 21
- 52W Active Breadth
- 40.4%
- Sector Scope
- HK Healthcare
- Sector Rank
- 166 of 257
- Sector Percentile
- 35.5%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
HK Healthcare
- Tracked Peers
- 100
- 4W Rank
- - of 100
- Avg 1W
- -1.3%
- Avg 4W
- -12.8%
- Trend Breadth
- 6.0%
- Positive MD
- 10.0%
HK Biotechnology
- Tracked Peers
- 76
- 4W Rank
- 5 of 76
- Avg 1W
- -1.6%
- Avg 4W
- -17.5%
- Trend Breadth
- 3.9%
- Positive RS
- 5.3%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- -0.48
- 4W MD Change
- 44.5%
- Relative Strength
- -42.19
- 4W RS Change
- 8.2%
- Expectation
- Negative
- Probability
- 37.82%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 184.0K
- 13W Average
- 777.1K
- 52W Average
- 1.8M
- Vs 13W
- 0.2x
- Vs 52W
- 0.1x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 8.2%
- 52W Volatility
- 9.3%
- Upside Weeks
- 23
- Downside Weeks
- 29
- Downside Breadth
- 55.8%
- Avg Gain / Loss
- 7.6% / -6.6%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- HKG
- Country
- HK
- Sector
- Healthcare
- Industry
- Biotechnology
- Currency
- HKD
- Market Cap
- 818.9M
Opportunity signals
- No strong opportunity cluster is confirmed yet; monitor trend and Market Dynamics.
Risk signals
- Trend Signal is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Market Dynamics is negative, which weakens the current setup.
- The share remains more than 20% below its 52-week high.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 2.91 HKD | -3.3% | 4.23 HKD | 9.63 HKD | -0.48 | -42.19 | 184.0K | Off |
| 5 Jun 2026 | 3.01 HKD | -11.7% | 4.31 HKD | 10.30 HKD | -0.44 | -41.12 | 576.5K | Off |
| 29 May 2026 | 3.41 HKD | 2.7% | 4.38 HKD | 10.86 HKD | -0.47 | -34.25 | 1.1M | Off |
| 22 May 2026 | 3.32 HKD | 14.1% | 4.48 HKD | 11.37 HKD | -0.62 | -37.30 | 2.7M | Off |
| 15 May 2026 | 2.91 HKD | -3.0% | 4.58 HKD | 11.88 HKD | -0.87 | -45.97 | 2.0M | Off |
| 8 May 2026 | 3.00 HKD | -21.5% | 4.68 HKD | 12.30 HKD | -0.99 | -45.39 | 662.0K | Off |
| 1 May 2026 | 3.82 HKD | 1.3% | 4.81 HKD | 12.71 HKD | -0.94 | -28.92 | 60.5K | Off |
| 24 Apr 2026 | 3.77 HKD | 0.5% | 4.95 HKD | 13.12 HKD | -0.83 | -30.40 | 355.5K | Off |
| 17 Apr 2026 | 3.75 HKD | -2.3% | 5.07 HKD | 13.55 HKD | -0.61 | -31.40 | 424.5K | Off |
| 10 Apr 2026 | 3.84 HKD | -6.3% | 5.21 HKD | 13.97 HKD | -0.38 | -29.18 | 448.0K | Off |
| 3 Apr 2026 | 4.10 HKD | -1.9% | 5.39 HKD | 14.42 HKD | -0.41 | -22.19 | 373.5K | Off |
| 27 Mar 2026 | 4.18 HKD | 1.7% | 5.50 HKD | 14.84 HKD | -0.53 | -20.19 | 451.5K | Off |
| 20 Mar 2026 | 4.11 HKD | 5.9% | 5.63 HKD | 15.28 HKD | -0.59 | -22.55 | 692.2K | Off |
| 13 Mar 2026 | 3.88 HKD | 2.1% | 5.77 HKD | 15.69 HKD | -0.73 | -27.40 | 229.5K | Off |